Clinical Trials Logo

Clinical Trial Summary

The object of this research study is to test a standardized set of acupuncture points on migraine patients to reduce frequency and intensity of headaches. Acupuncture has been studied in prior research but the treatment points have varied between subjects, making it difficult to replicate studies.


Clinical Trial Description

Subjects will be recording daily headache activity on personal digital assistants (PDA's) for 12 weeks before and 12 weeks after 8 weeks of acupuncture intervention. MIDAS, HIT-6 and BDI-II measurements will be done at the beginning of the study (12 weeks pre-intervention), directly before the intervention, directly after, and 12 weeks post-intervention. Measurements will be compared before and after intervention. This is a follow-up to a successful earlier study when these same acupuncture points were used on subjects with chronic daily headache, the majority being migraine. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00714727
Study type Interventional
Source Memorial Medical Center
Contact
Status Completed
Phase Phase 1
Start date July 2008
Completion date January 2011

See also
  Status Clinical Trial Phase
Completed NCT06342232 - The Efficacy of Neurofeedback Mindfulness in Migraine Management N/A
Completed NCT02351544 - Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches N/A
Completed NCT00665236 - Craniosacral Therapy in Migraine: A Feasibility Study N/A
Completed NCT01706003 - The Utility of Telemedicine in the Management of Migraine
Terminated NCT01944059 - Theramine® in the Prevention of Migraine Headache Phase 4
Terminated NCT01629329 - Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine Phase 4
Completed NCT00792636 - A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period Phase 4
Not yet recruiting NCT05536635 - Effect of Breathing Techniques on Migraine Attacks and Severity N/A
Completed NCT00442221 - The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months Phase 3
Completed NCT02057315 - Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine Phase 1/Phase 2
Completed NCT00109083 - A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine Phase 2
Completed NCT02098499 - Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial Phase 4
Completed NCT00434083 - To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches Phase 3
Completed NCT00960245 - Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions Phase 1
Completed NCT02856802 - An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg) Phase 2
Completed NCT00355056 - PREMIUM Migraine Trial N/A
Completed NCT01118988 - Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents N/A
Completed NCT00433732 - To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches Phase 3
Completed NCT00750594 - Patent Foramen Ovale in Children With Migraine Headaches N/A